| Course | NUR 600 Advanced Integrative Concepts: Pathophysiology, Pharmacology and Assessment |
|---|---|
| Topic | Topic 7 |
| Paper type | Integrated case study |
| Length | About 980 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for NUR 600 Topic 7
Each Section Depends on the One Before: An Integrated Case of New Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
NUR-600: Advanced Integrative Concepts: Pathophysiology, Pharmacology and Assessment
Topic 7 Assignment
[Instructor Name]
September 17, 2029
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Each Section Depends on the One Before: An Integrated Case of New Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
The Case and the Question
Mrs. R. G., 66, a composite patient with heart failure with preserved ejection fraction, chronic kidney disease, type 2 diabetes and hypertension, had an irregular pulse at her last visit, and her electrocardiogram showed atrial fibrillation at a rate in the mid-90s. She is now decongesting on a loop diuretic and a sodium-glucose cotransporter 2 inhibitor. The question for this case is what caused her atrial fibrillation and how it should be treated, and the answer is built so that each part depends on the part before it.
Mechanism, Ending With What to Examine
Atrial fibrillation arises when the atria become electrically and structurally abnormal. In heart failure with preserved ejection fraction, the left atrium works against a stiff ventricle at high pressure for years, enlarges and becomes fibrotic, which creates the substrate for fibrillation. Hypertension and obesity add to the same process. But other causes can produce new atrial fibrillation and must be considered: hyperthyroidism, which increases atrial excitability; valvular disease, especially mitral valve disease, which enlarges the atrium by a different route; acute illness such as infection or pulmonary embolism; and alcohol.
The mechanism therefore names what is worth examining: four things that could distinguish these causes. Signs of thyroid excess (resting tremor, warm moist skin, lid lag, goiter); a murmur, especially of mitral regurgitation or stenosis; signs of acute illness (fever, new focal lung findings, unilateral leg swelling); and an alcohol history. The mechanism also makes six parts of a full examination pointless for this question: the neurological examination, abdominal examination, skin survey beyond the thyroid signs, joint examination, detailed eye examination and breast examination, none of which could distinguish among the candidate causes, so the examination section begins already constrained.
Examination, Ending With Two Processes Removed
Findings: no tremor, skin cool and dry, no lid lag, no goiter; no murmur on careful auscultation at the apex and base, and the echocardiogram from her earlier visit showed no significant valve disease; temperature 36.8 C, lungs with resolving basal crackles only, legs with symmetric edema that has decreased with diuresis; she drinks one glass of wine a week. Her thyroid-stimulating hormone, drawn at the first visit, was normal.
The examination removes two candidate processes. Hyperthyroidism is excluded by the absence of clinical signs and the normal thyroid test. Valvular disease is excluded by the absence of a murmur and the echocardiogram. Acute illness is unlikely without fever or a new focal finding, and her symmetric edema argues against thrombosis; alcohol is not a factor. The remaining explanation is the one her mechanism predicted: atrial remodeling from long-standing hypertension and heart failure with preserved ejection fraction. The therapeutic section therefore starts with a shorter list, because there is no thyroid storm to treat, no valve to repair and no infection to clear.
Therapy, Defended Partly on What Was Excluded
Two decisions follow: stroke prevention and rate control. For stroke prevention, her CHA2DS2-VASc score (Lip et al., 2010) is high, with points for hypertension, age 65 to 74, diabetes, female sex and heart failure, and anticoagulation is recommended (Joglar et al., 2024). A direct oral anticoagulant is preferred to warfarin in patients without moderate or severe mitral stenosis or a mechanical valve; apixaban reduced stroke and systemic embolism and caused less major bleeding than warfarin in a large trial (Granger et al., 2011). The exclusion of valvular disease by examination and echocardiography is what makes a direct oral anticoagulant appropriate for her; had the examination found mitral stenosis, warfarin would have been required. Apixaban is chosen, with its dose checked against her age, weight and creatinine.
For rate control, a beta-blocker or a nondihydropyridine calcium channel blocker are both options in heart failure with preserved ejection fraction. The examination and earlier spirometry, which excluded airway disease, remove the main reason to avoid a beta-blocker. Because she already takes amlodipine, adding diltiazem would combine two calcium channel blockers, and her edema has only just improved; a beta-blocker is chosen instead. Metoprolol succinate, started at a low dose, targets a resting rate below about 110 initially, with further adjustment by symptoms.
The Loose End, Kept
One finding does not fit neatly and is kept rather than dropped. Her hemoglobin is 11.8 g/dL, and iron studies have not yet been done. Anemia can worsen heart failure symptoms, and starting anticoagulation in a patient with an unexplained anemia raises the question of a slow gastrointestinal blood loss that anticoagulation would worsen. The plan therefore includes iron studies before or alongside the first weeks of apixaban, and a stool test or referral if iron deficiency is found. A case with no loose ends usually means an awkward finding was quietly left out.
Rate control also interacts with her other conditions. A beta-blocker can blunt the warning symptoms of hypoglycemia, which matters because she has diabetes, so her glucose-lowering regimen is reviewed at the same visit. And because a slower heart rate lengthens the time her stiff ventricle has to fill, rate control may itself relieve some of her breathlessness, which gives the plan an early sign that it is working.
What Would Break the Chain
The chain breaks at the examination if a new finding appears: a murmur not heard before, signs of thyroid excess, or a fever, any of which would reopen a candidate cause and change the therapy. It breaks at the therapy if iron studies reveal significant iron deficiency with a possible bleeding source, which would put the anticoagulant decision on hold until the source is found, or if her rate remains high despite the beta-blocker, which would prompt reconsideration of rhythm control. Stating these points is what distinguishes a reasoned case from a reconstruction written after the answer was known.
References
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., Bahit, M. C., Diaz, R., Easton, J. D., Ezekowitz, J. A., Flaker, G., Garcia, D., Geraldes, M., Gersh, B. J., Golitsyn, S., ... Wallentin, L. (2011). Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981-992. https://doi.org/10.1056/NEJMoa1107039
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., ... Van Wagoner, D. R. (2024). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149(1), e1-e156. https://doi.org/10.1161/CIR.0000000000001193
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest, 137(2), 263-272. https://doi.org/10.1378/chest.09-1584
What the NUR 600 Topic 7 instructions ask for
Topic 7 in NUR-600 asks students to present an integrated case study. Strong case studies make each section depend visibly on the one before, ending the mechanism section with what must be examined and the examination section with what has been excluded, so that therapy can be defended partly by those exclusions. Students should keep one unresolved finding rather than dropping it, explain what new finding would break the chain of reasoning and cite current guidelines and risk scores for the therapy chosen. A required heading structure does not prevent integration; the joins between sections are where integration shows. Joins between sections show integration.
Inside the NUR 600 Topic 7 example
The finished case study can be tested by covering a section and asking whether the next one still makes sense, and it does not. The mechanism section ends by naming the four things worth examining and the six that are now pointless, so the examination section opens already constrained. The examination section ends by removing two candidate processes, so the therapeutic section starts with a shorter list than it would otherwise have had. The agent chosen at the end is defended partly on what the examination excluded, which is the sentence a grader looks for. One finding refuses to fit the working account, and the paper keeps it visible rather than quietly dropping it, offering two readings and saying which one it would test first.
Where the marks sit in the NUR 600 Topic 7 rubric
Faculty reward sections that visibly depend on each other. An Excellent case ends the mechanism section with what to examine and the examination with two causes removed, thyroid excess and valve disease. Credit goes to defending anticoagulation with a CHA2DS2-VASc score from Lip and colleagues and apixaban from Granger and colleagues' ARISTOTLE trial. The rubric values rate control following Joglar and colleagues' guideline. Strong cases keep a hemoglobin of 11.8 as a loose end. Top marks go to naming what would break the chain, such as a new murmur.
NUR 600 Topic 7 help: mistakes that cost marks
Three technically sound sections with nothing in the second depending on the first is the exact failure this topic is written to expose, and it is caught by a simple test: could the examination section have been written before the mechanism section, unchanged? A second loss comes from an examination that reports everything, since a case study whose exam is a full survey has not used the mechanism it just spent two pages building. Therapeutic choices defended only by indication ignore the two sections above them. Marks also go for a case with no loose ends, which usually means an awkward finding was dropped. Papers that never say what would break the chain present a reconstruction as though no judgment had been made anywhere in it.
Get an NUR-600 Topic 7 example written to your instructions
Send the NUR-600 Topic 7 assignment instructions and the rubric your classroom posts, with the case your section assigns and any required headings. We write a custom example to those criteria, built as a chain where each section constrains the next, with one finding left unresolved on purpose, in 24 to 48 hours. The first one is free.
More NUR 600 papers and MSN samples
- NUR 600 Topic 1: Integration Rationale Paper
- NUR 600 Topic 2: Symptom to Mechanism Analysis
- NUR 600 Topic 3: Focused Exam Write-up
- NUR 600 Topic 4: Pharmacology Case Workup
- NUR 600 Topic 5: Differential DQ Pair
- NUR 600 Topic 6: Comorbidity Interaction Paper
- NUR 600 Topic 8: Management Plan Defense
- NUR 621 Topic 7: Capital Request Analysis
- NUR 590 Topic 7: Dissemination and Appendix Assembly
- NUR 630 Topic 7: Stakeholder and Sustainability Plan
- NUR 550 Topic 7: Benchmark Population Proposal
NUR 600 Topic 7 questions, answered
How can a reader tell whether the sections actually depend on each other?
Cover one and see whether the next still stands. If the examination section reads identically without the mechanism above it, no dependency exists and the paper is three essays sharing a patient. The strongest sign of real integration is a sentence in the later section that could not have been written before the earlier one was finished.
Should a case study leave anything unresolved?
One thing, usually. Real cases contain a result that does not sit comfortably with the working account, and a paper where everything aligns has generally been tidied at the expense of honesty. Keeping the awkward finding visible, offering two readings of it and saying which you would pursue first reads at graduate level as judgment rather than as confusion.
Does the required heading structure prevent integration?
No, though it makes the joints easier to skip. If your instructions fix the headings, write the dependency into the last paragraph of each section: state what this part hands forward and what it has removed from consideration. The structure stays compliant and the reasoning becomes visible, which is what the rubric is usually reaching for.
Where can I find a free NUR 600 Topic 7 sample paper?
The integrated case for NUR 600 Topic 7 covers the case and question, the mechanism ending with what to examine, the examination ending with processes removed, therapy defended on exclusions, the loose end and what would break the chain. Send your NUR 600 Topic 7 prompt and a paper follows free.
Should a case study leave something unresolved in NUR 600 Topic 7?
One thing, usually. Keeping the unexplained mild anemia shows honest reasoning, and the plan says how it will be investigated.